|Bid||152.8000 x 1200|
|Ask||153.0000 x 1200|
|Day's Range||152.7700 - 154.3875|
|52 Week Range||111.6100 - 158.6600|
|PE Ratio (TTM)||116.89|
|Earnings Date||Jul 18, 2018 - Jul 23, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||152.13|
“The Board currently is undertaking a thorough and deliberate analysis of Elliott Management's proposal to acquire the Company for $160 per share in cash and will continue to take the time necessary to complete this review notwithstanding Elliott Management's attempts to publicly pressure the Board and management team,” the board wrote in a press release. Athenahealth committed to “promptly” communicating the results of its analysis. Athenahealth’s stock chart appears to corroborate the view.
The athenahealth Board of Directors takes very seriously its obligation to protect shareholders and to take only those actions that are in the best interests of all shareholders. The Board currently is undertaking a thorough and deliberate analysis of Elliott Management's proposal to acquire the Company for $160 per share in cash and will continue to take the time necessary to complete this review notwithstanding Elliott Management's attempts to publicly pressure the Board and management team. The Board will communicate the results of this analysis and its recommendation promptly.
Elliott Management has said that majority of athenahealth shareholders support a sale of the company, a force that may push athenahealth to take up Elliott’s $6.4 billion bid.
Elliott Management Corporation (“Elliott”) today sent a letter to the Board of Directors of athenahealth, Inc. (ATHN) (the “Company” or “athenahealth”) following up on Elliott’s recent proposal to acquire athenahealth for $160 per share in cash. According to the letter, the investment community broadly agrees that athenahealth has struggled as a public company and should immediately explore a value-maximizing sale, including consideration of Elliott’s offer.
Athenahealth has a unique Austin office inside of the old Seaholm Power Plant. After shedding jobs in other cities in 2017, the company is steadily growing here and is in need of engineering talent.
Stock Research Monitor: ATHN, HQY, and TDOC LONDON, UK / ACCESSWIRE / May 18, 2018 / If you want a free Stock Review on EVH sign up now at www.wallstequities.com/registration . Today's research on WallStEquities.com ...
The Boston asset manager was athenahealth's largest shareholder at the end of 2017. A few months later, that had changed.
Elliott Management Corp. said it has heard nothing from Athenahealth Inc. or its board after proposing on May 7 to acquire the health technology company for $6.46 billion. “Since that time, we have heard nothing from the company beyond its cursory, boilerplate press release,” Jesse Cohn, an Elliott partner and senior portfolio manager, said in a letter to Athenahealth’s board Monday. “We are also aware that other parties have conveyed directly to the company interest in acquiring Athenahealth,” Cohn wrote.
Elliott Management Corporation (“Elliott”) today released a letter to the Board of Directors of athenahealth, Inc. (ATHN) (the “Company” or “athenahealth”) regarding Elliott’s proposal to acquire athenahealth for $160 per share in cash. The letter outlined Elliott’s concerns with athenahealth’s refusal thus far to engage with any of the parties, including Elliott, that have expressed interest in acquiring athenahealth. The letter also reiterated Elliott’s view that immediate engagement with Elliott to explore a take-private transaction is the right course forward for all athenahealth stakeholders.
On today's episode of the Tech Talk Tuesday podcast, Ryan McQueeney discusses Athenahealth (ATHN), a medical technology company that has found itself the target of an activist takeover from Paul Singer's Elliott Management.
NEW YORK, NY / ACCESSWIRE / May 8, 2018 / Athenahealth shares were skyrocketing on Monday and almost touched the stock's 52-week high after it was revealed that hedge fund Elliott Management has proposed an unsolicited offer to take the company private. The company agreed to buy Israeli-based Frutarom for $6.4 billion which many on Wall Street fear is a risky move for the company. The company announced first quarter 2018 earnings reporting 12% revenue growth, 34% operating income growth, and 12% EPS growth compared to the prior-year period.
Activist investor Elliott Management Corp. is pushing to take Athenahealth Inc. private, arguing the health-care software company is botching an opportunity to expand and, as a result, isn’t providing adequate returns to shareholders. Elliott, which has an 8.9% stake in Athenahealth, offered on Monday to buy the remainder of the company for $160 a share, a 27% premium to its Friday closing price. “It is clear to us and becoming clear to many others that Athenahealth’s potential will never be realized without the kind of operational change that the company seems unable to deliver,” Elliott said in a letter.
to consider "strategic options," $35 billion activist investor Elliott Management on Monday launched a hostile bid to buy the healthcare technology company for as much as $6.9 billion including debt, in an all-cash offer. Athenahealth shares rose 16%, or $19.93 cents to $146.02. The bid, for $160 a share, may be the latest example of Elliott Management shifting from its bread-and-butter activist activists into the world of private equity, following its move recently to set up a Menlo Park, Calif.-based private equity team, Evergreen Coast Capital Partners.
The offer from Elliott, which has pressured Athenahealth to make operational and strategic changes, represents a premium of about 27 percent to the healthcare company's Friday closing price. The hedge fund said it had "extensive private engagement" with Athenahealth's management and board during the past year, and believes that the company, which former General Electric Co (GE.N) Chief Executive Jeff Immelt joined as chairman this year, cannot make the changes it needs while it remains a public company.
Prominent athenahealth investor Elliott Management Corp. is offering about $6.5 billion to take the medical billing software maker private after saying it has grown frustrated with the company's performance. Athenahealth stock soared Monday after the shareholder outlined its unsolicited bid. The investor says it owns about a 9 percent stake in athenahealth, and the company has not made the changes it needs to grow and create value as a public company.
In the months leading up to a $6.4 billion takeover bid announced Monday, activist investor Elliott Management grew increasingly frustrated with months of attempts on the part of athenahealth Inc. to restructure itself.
Shares of Athenahealth (ATHN) opened more than 20% higher on Monday after Paul Singer's Elliott Management offered to buy the healthcare technology company in an all-cash deal valued at $160 per share.
Elliott Management Corp. confirmed Monday, May 7, it made a bid for Athenahealth Inc. "Elliott proposes to acquire Athenahealth for $160 per share in cash. Last year, Elliott, run by hedge fund manager Paul Singer, bought a 9.2% stake in Athenahealth.
CNBC’s David Faber discusses the all-cash bid from Paul Singer’s Elliott Management for Athenahealth, which values that company at $160 per share.
May.07 -- Athenahealth Inc. shares rose after Elliott Management Corp. bid to acquire the medical company for $160 a share. Bloomberg’s Abigail Doolittle has the latest on "Bloomberg Markets."